Summary

● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.

● The company has poor fundamentals for a short-term investment strategy.


Strengths

● The prospective high growth for the next fiscal years is among the main assets of the company

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● For the last week, the earnings per share forecast has been revised upwards. According to recent estimates, analysts give a positive overview of the stock

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.


Weaknesses

● Stock prices approach a strong long-term resistance in weekly data at EUR 79.1.

● The company is in debt and has limited leeway for investment

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● With an enterprise value anticipated at 4.51 times the sales for the current fiscal year, the company turns out to be overvalued.

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 42.33 times its estimated earnings per share for the ongoing year.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.